Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Choline Supplementation in Fetal Alcohol Spectrum Disorders
NCT02735473Phase 2Completed
- Sponsor
- University of Minnesota
- Start
- Jun 2016
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of choline in Fetal Alcohol Spectrum Disorders (FASDs), sponsored by University of Minnesota. Started Jun 2016; status: completed.
02
Drugs
choline
03
Conditions
Fetal Alcohol Spectrum Disorders (FASDs)
Beyond the preview
Go deeper on NCT02735473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02735473.